Patient & Visitor InformationContact Us
  • Brain Protocols

  • Glioblastoma

    1. LS-P-DCVAX: A phase III clinical trial evaluating DCVax® L, autologous dendritic cells pulsed with tumor lysate antigen for the treatment of glioblastoma multiforme (GBM).
      PI: Heinrich Elinzano, MD
      Sites: Rhode Island Hospital
      Learn more about this study

    2. BrUOG B-263: PSMA ADC for Recurrent Glioblastoma Multiforme (GBM): A Phase II Brown University Oncology Group Study
      PI: Heinrich Elinzano, MD
      Sites: Rhode Island Hospital
      Learn more about this study